Hasandalan, Johndejay G.
HRN: 16-32-65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2024
CEFTRIAXONE 1G (VIAL)
11/02/2024
11/08/2024
IV
2g
Q12h
Orbital Apex Syndrome Prob Infectious In Origin
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes